The present invention relates to compounds with the formula (I), (II), (III) or (IV):
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, X and Z are as defined herein, and also to pharmaceutical compositions comprising the compounds, as well as methods of use of the compounds for treatment of disorders associated with human 11-β-hydroxysteroid dehydrogenase type 1 enzyme and for the preparation of a medicament which acts on the human 11-β-hydroxysteroid dehydrogenase type 1 enzyme.
                            本发明涉及具有式(I)、(II)、(III)或(IV)的化合物:其中R1、R2、R3、R4、R5、R6、R7、X和Z如本文所定义的,并且还涉及包括该化合物的制药组合物,以及使用该化合物治疗与人类11-β-羟基类
固醇脱氢酶1型酶相关的疾病的方法,以及制备作用于人类11-β-羟基类
固醇脱氢酶1型酶的药物的方法。